Using examples from recent FDA regulatory proceedings, Jonas Hines and colleagues critique the medical device premarket review and identify eight weaknesses in the process that should be remedied.

Further information:

Article source

Related posts:

1. ACI Announces Agenda Highlights for Upcoming Medical Devices Conference
2. Agenda Highlights Announced for ACI’s Medical Devices Conference
3. Ghostwriting at Elite Academic Medical Centers in the United States
4. Medical-Device Regulator to Step Down
5. Excel Spreadsheets and FDA Device Regulations – Webinar by GlobalCompliancePanel